3D visualization of SARS-CoV-2 infection and receptor distribution in Syrian hamster lung lobes display distinct spatial arrangements

• Published in: bioRxiv 2021-03
• Main Authors: Tomris, Ilhan, Bouwman, Kim M, Adolfs, Youri, Noack, Danny, Roosmarijn Van Der Woude, Herfst, Sander, Boons, Geert-Jan, Haagmans, Bart, Pasterkamp, R Jeroen, Rockx, Barry, De Vries, Robert Paul
• Format: Article
• Language: English
• Subjects: ACE2; Angiotensin; Angiotensin-converting enzyme 2; Bronchus; Infections; Infectivity; Membrane fusion; Peptidyl-dipeptidase A; Proteins; Serine; Serine proteinase; Severe acute respiratory syndrome coronavirus 2; Spike protein; Transcriptomics; Volumetric analysis
• DOI: 10.1101/2021.03.24.435771

SARS-CoV-2 attaches to angiotensin-converting enzyme 2 (ACE2) to gain entry into cells after which the spike protein is cleaved by the transmembrane serine protease 2 (TMPRRS2) to facilitate viral-host membrane fusion. ACE2 and TMPRRS2 expression profiles have been analyzed at the genomic, transcriptomic, and single-cell RNAseq level, however, biologically relevant protein receptor organization in whole tissues is still poorly understood. To describe the organ-level architecture of receptor expression, related to the ability of ACE2 and TMPRRS2 to mediate infectivity, we performed a volumetric analysis of whole Syrian hamster lung lobes. Lung tissue of infected and control animals were stained using antibodies against ACE2 and TMPRRS2, combined with fluorescent spike protein and SARS-CoV-2 nucleoprotein staining. This was followed by light-sheet microscopy imaging to visualize expression patterns. The data demonstrates that infection is restricted to sites with both ACE2 and TMPRRS2, the latter is expressed in the primary and secondary bronchi whereas ACE2 is predominantly observed in the terminal bronchioles and alveoli. Conversely, infection completely overlaps at these sites where ACE2 and TMPRSS2 co-localize. Competing Interest Statement The authors have declared no competing interest.